期刊名称：MOLECULAR CARCINOGENESIS
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
Aims and Scope
Molecular Carcinogenesis presents information describing investigations of molecular aspects of the mechanisms involved in chemical, physical, and viral (biological) carcinogenesis. Areas of interest include, but are not limited to, the structure, expression, or function of genes or gene products associated with normal growth and differentiation and alterations in neoplasia; characterization of genes or gene products expressed in preneoplastic or neoplastic cells; molecular studies that define a specific function of a tumor-associated protein or its effects on cellular function; virtually all research on molecular aspects of oncogenes, tumor suppressor genes, and their gene products; carcinogenesis studies in transgenic mice; and research on human tumor viruses.
Readership
Cancer biologists · oncologists · virologists · geneticists · cellular and molecular biologists
Abstracting and Indexing Information
- Abstracts in Anthropology (Baywood Publishing)
- BIOBASE (Elsevier)
- Biochemistry & Biophysics Citation Index™ (Thomson ISI)
- Biological Abstracts® (Thomson ISI)
- BIOSIS Previews® (Thomson ISI)
- Biotechnology Citation Index™ (Thomson ISI)
- CAB HEALTH (CABI)
- CABDirect (CABI)
- Cambridge Scientific Abstracts (CSA/CIG)
- CAS: Chemical Abstracts Services ()
- Chemical Abstracts Service/SciFinder (ACS)
- CSA Biological Sciences Database (CSA/CIG)
- CSA Environmental Sciences & Pollution Management Database (CSA/CIG)
- CSA Oncogenes and Growth Factors Abstracts (CSA/CIG)
- Current Awareness in Biological Sciences (Elsevier)
- Current Contents®/Life Sciences (Thomson ISI)
- EMBASE/Excerpta Medica (Elsevier)
- Embiology (Elsevier)
- Index Medicus/MEDLINE/PubMed (NLM)
- Journal Citation Reports/Science Edition (Thomson ISI)
- Leeds Medical Information (University of Leeds)
- MEDLINE/PubMed (NLM)
- Reference Update (Thomson ISI)
- Review of Medical and Veterinary Mycology ()
- Science Citation Index Expanded™ (Thomson ISI)
- Science Citation Index® (Thomson ISI)
- SCOPUS (Elsevier)
- SIIC Databases (Sociedad Iberoamericana de Informacion Cientifica)
- Soybean Abstracts Online (coverage dropped)
- VINITI (All-Russian Institute of Science & Technological Information)
- Web of Science® (Thomson ISI)
Instructions to Authors
Submit all new manuscripts online at ScholarOne (formerly known as Manuscript Central).
Launch your web browser and go to ScholarOne (formerly known as Manuscript Central). Check for an existing account. If you are submitting for the first time, and you do not have an existing account, create a new account. Follow all instructions.
At the end of a successful submission, a confirmation screen with manuscript number will appear and you will receive an e-mail confirming that the manuscript has been received by the journal. If this does not happen, please check your submission and/or contact the editorial office at: mc@wiley.com .
Submit manuscript and all figures as individual files. Please do not mail paper copies of your manuscript.
RAPID REVIEW OF MANUSCRIPTS SUBMITTED PREVIOUSLY TO ANOTHER JOURNAL:
As stated in the “Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication” ( http://www.icmje.org ; Updated February 2006): “ If the manuscript has been submitted previously to another journal, it is helpful to include the previous editor’s and reviewers’ comments with the submitted manuscript, along with the authors’ responses to those comments. Editors encourage authors to submit these previous communications and doing so may expedite the review process.”
For manuscripts previously submitted to other journals with impact factor more than 6, if authors include previous editor’s and reviewers’ comments along with their responses, Molecular Carcinogenesis will guarantee a rapid (within a week) in-house assessment, with three possible outcomes:
a) Acceptance or acceptance with minor changes (no additional external reviews needed);
b) Rejection;
c) Additional external review needed; in this case the authors will have the possibility of accepting the additional external review or withdrawing the manuscript.
Editorial office contact information:
Molecular Carcinogenesis Editorial Receiving Office
Attn: Stefanie Alaimo
John Wiley & Sons, Inc.
111 River Street, 8th Floor
Hoboken, NJ 07030
Phone: 201-748-6930
E-mail: mc@wiley.com
Manuscript Preparation
Brief communications should not exceed 2,500 words (this does not include the abstract and title.) They can report preliminary data or ongoing work that does not warrant a full-length article. These communications must be complete manuscripts in which the traditional sections of the research paper may be combined. Include a complete reference list.
Research papers should contain the following sections: title page, abstract, introduction, materials and methods, results, discussion, acknowledgments (optional), references, tables, and figure legends. Use generic names of drugs and give manufacturer, city, and state or country of all trademarked equipment mentioned in the text.
Working Hypothesis is a forum for presenting ideas for further experimentation. Each Working Hypothesis is the author's personal viewpoint, based either on the author's own work or on the published literature. Each should be no longer than 20 double-spaced pages and contain no more thn 20 references and two figures.
Title page. Give a descriptive title with no abbreviations. Provide first and last names of each author and department and institutional affiliations. Give full address, telephone, and telefax of corresponding author. On the second page, acknowledge grant support and provide definitions for all abbreviations used, an abbreviated title, and three to five key words or terms not used in the article title, chosen as far as possible from the National Library of Medicine Medical Subject Headings . Avoid nonstandard abbreviations; do not abbreviate single words (see "Conventions and Nomenclature" for acceptable reporting methods and abbreviations).
Abstract. Limit the abstract to a single paragraph of not more than 250 words. It must describe the work and include the purpose, a brief statement of methods, and the results. Avoid statements such as "methods will be described" or "other data will be presented." Working Hypotheses do not have abstracts.
References.
Wiley's Journal Styles Are Now in EndNote
EndNote is a software product that we recommend to our journal authors to help simplify and streamline the research process. Using EndNote's bibliographic management tools, you can search bibliographic databases, build and organize your reference collection, and then instantly output your bibliography in any Wiley journal style.
Download Reference Style for this Journal: If you already use EndNote, you can download the reference style for this journal.
How to Order: To learn more about EndNote, or to purchase your own copy, click here .
Technical Support: If you need assistance using EndNote, contact endnote@isiresearchsoft.com , or visit www.endnote.com/support .
The accuracy of references is the responsibility of the authors. Only published papers and those in press should be included in the reference list. Unpublished data and submitted manuscripts must be cited parenthetically within the text. Any personal communication and its date should be cited within the text; permission in writing from the communicator is required to publish the information. References should be prepared in the citation-sequence style described in the Council of Biology Editors Style Manual (6th edition, Cambridge University Press). References should be numbered in order of their first mention in the text and cited within square brackets on the line. In the reference list, list all authors if there are six or fewer; list the first three and et al. if there are seven or more. Index Medicus abbreviations should be used for journal titles; the titles of unindexed journals should be spelled out in full. Use the following style for the references:
Journal
1. Sherman ML, Shafman TD, Kufe DW. Modulation of cyclic AMP levels and differentiation by adenosine analogs in mouse erythroleukemia cells. J Cell Physiol 1988;134:429–436.
Book chapter
2. Gilmore ML, Rouse ST, Heilman CJ, Nash, NR, Levey AI. Receptor fusion proteins and analysis. In: Ariano MA, editor. Receptor localization. New York: Wiley-Liss; 1998. p 75–90.
Book
3. Voet D, Voet JG. Biochemistry: text book for students. New York: John Wiley & Sons, Inc.; 1990. 1223 p.
Tables. Cite each table at the most appropriate point in the text. Tables should present comparisons of data that are too cumbersome to describe in the text, and not merely repeat text information. Each table should be typed double-spaced on a separate sheet of paper and should include a title and, in a footnote, definitions of all abbreviations used in it (even if abbreviations are defined in the text), indicated by the following symbols in this order: *, †, ‡, §,  .
Figures. Figures should be good quality and high contrast. High-resolution (300 dpi, laser print) computergraphics will also be accepted. The files should be submitted in either TIF or EPS format. All letters, numbers, and symbols must be large enough that when reduced they will remain at least 2 mm high. Figures not properly prepared will be returned to the contributor for revision. Cite all figures at the most appropriate point in the text. Each figure requires a separate double-spaced legend. Figure legends should briefly describe the information presented; a detailed description of the procedure should appear in Materials and Methods. Abbreviations used in figures and photographs must exactly match those used in the text. Do not submit original artwork or recordings. Color will be printed only at the author's expense. Upon acceptance of color illustrations, the publisher will proide price quotes.
Conventions and Nomenclature are of the style presented in CBE Style Manual: A Guide for Authors, Editors, and Publishers in the Biological Sciences , published by the Council of Biology Editors. The manual is available from the Council of Biology Editors, 9650 Rockville Pike, Bethesda, MD 20814. American spelling will be used throughout as presented in Webster's Ninth New Collegiate Dictionary . For specific nomenclature, the following sources will be consulted: Handbook of Chemistry and Physics and The Merck Index (chemical symbols and formulas), Enzyme Nomenclature (International Union of Biochemistry), Index Bergeyana (bacteria nomenclature), and Biochemical Nomenclature and Related Documents (International Union of Biochemistry).
Note to NIH Grantees. Pursuant to NIH mandate, Wiley-Blackwell will post the accepted version of contributions authored by NIH grant-holders to PubMed Central upon acceptance. This accepted version will be made publicly available 12 months after publication. For further information, see www.wiley.com/go/nihmandate .
Guidelines for Submission
Text
Software and format. Microsoft Word 6.0 is preferred. Please note: This journal does not accept Microsoft WORD 2007 documents at this time. Please use WORD’s “Save As” option to save your document as an older (.doc) file type. Refrain from complex formatting; the Publisher will style your manuscript according to the Journal design specifications. Do not use desktop publishing software such as Aldus PageMaker or Quark XPress. If you prepared your manuscript with one of these programs, export the text to a word processing format. Please make sure your word processing program's "fast save" feature is turned off. Please do not deliver files that contain hidden text: for example, do not use your word processor's automated features to create footnotes or reference lists.
File names. Submit the text and tables of each manuscript as individual Word Doc files. Text files should be given the three-letter extension that identifies the file format. Macintosh users should maintain the MS-DOS "eight dot three" file-naming convention.
Illustrations
Resolution. Journal quality reproduction will require grayscale and color files at resolutions yielding approximately 300 dpi. Bitmapped line art should be submitted at resolutions yielding 600-1200 dpi. These resolutions refer to the output size of the file; if you anticipate that your images will be enlarged or reduced, resolutions should be adjusted accordingly. All print reproduction requires files for full color images to be in a CMYK color space. If possible, ICC or ColorSync profiles of your output device should accompany all digital image submissions.
Software and format. All illustration files should be in TIFF or EPS (with preview) formats. Do not submit native application formats. File names . Illustration files should be given the 2- or 3-letter extension that identifies the file format used (i.e., .tif, .eps).”
Editorial Board
E d i t o r - i n - C h i e f
John DiGiovanni
UT M. D. Anderson Cancer Center
Smithville, Texas
C o n s u l t i n g E d i t o r s
Thomas J. Slaga
UT Health Science Center - San Antonio
San Antonio, Texas
J. Carl Barrett
Novartis Institutes for BioMedical Research, Inc.
Cambridge, Massachusetts
E x e c u t i v e E d i t o r s
Stuart H. Yuspa
National Cancer Institute
Bethesda, Maryland
Robert Weinberg
Whitehead Institute for Biomedical Research
Cambridge, Massachusetts
A s s o c i a t e E d i t o r s
Rajesh Agarwal
School of Pharmacy
School of Pharmacy
Denver, Colorado
Allan Balmain
University of California San Francisco
Cancer Center, San Francisco, California
Mariano Barbacid
Centro Nacional de Investigaciones Oncologicas
Instituto de Salud Carlos III
Madrid, Spain
Mina Bissell
Lawrence Berkeley Laboratory
Berkeley, California
Maarten Bosland
New York University School of Medicine
Tuxedo, New York
G. Tim Bowden
Health Science Center
University of Arizona
Tucson, Arizona
Shawn B. Bratton
College of Pharmacy
The University of Texas at Austin
Austin, Texas
Ding-Shinn Chen
National Taiwan University
Taipei, Taiwan
Nancy Colburn
National Cancer Institute
Frederick, Maryland
Claudio Conti
UT M. D. Anderson Cancer Center
Smithville, Texas
Roderick H. Dashwood
Linus Pauling Institute
Oregon State University
Corvallis, Oregon
Linda A. DeGraffenried
School of Natural Sciences
The University of Texas at Austin
Austin, Texas
Kevin Coombes
UT M. D. Anderson Cancer Center
Houston, Texas
Larry Donehower
Baylor College of Medicine
Houston, Texas
Zigang Dong
Hormel Institute
University of Minnesota
Austin, Minnesota
Norman R. Drinkwater
McArdle Laboratory for Cancer Research
University of Wisconsin
Madison, Wisconsin
John M. Essigmann
Massachusetts Institute of Technology
Cambridge, Massachusetts
Adam Glick
Pennsylvania State University
University Park, Pennsylvania
Jennifer R. Grandis
School of Medicine
University of Pittsburgh
Pittsburgh, Pennsylvania
Philip C. Hanawalt
Stanford University
Stanford, California
Randy S. Haun
University of Arkansas for Medical Sciences
Little Rock, Arkansas
Peter Herrlich
Kernforschungszentrum Karlsruhe
Institut fur Genetik und Toxikologie
Karlsruhe, Germany
Shuk-Mei Ho
Department of Environmental Health
University of Cincinnati
Cincinnati, Ohio
Eliezer Huberman
Argonne National Laboratory
Argonne, Illinois
Mien-Chie Hung
UT M. D. Anderson Cancer Center
Houston, Texas
David Hunter
Harvard School of Public Health
Boston, Massachusetts
Stephen D. Hursting
Department of Human Ecology
College of Natural Sciences
Austin, Texas
David Johnson
UT M. D. Anderson Cancer Center
Smithville, Texas
Fred Kadlubar
National Center for Toxicology Research
Jefferson, Arkansas
Michael Karin
University of California at San Diego
La Jolla, California
Marcelo Kazanietz
University of Pennsylvania School of Medicine
Philadelphia, Pennsylvania
Fadlo Khuri
Emory University School of Medicine
Atlanta, Georgia
Paul Kleihues
International Agency for Research on Cancer
Lyon, France
Andres J. P. Klein-Szanto
Fox Chase Cancer Center
Philadelphia, Pennsylvania
Pratap Kumar
Deparment of Urology, Health Science Center
University of Texas
San Antonio, Texas
Donna Kusewitt
UT MD Anderson Cancer Center
Houston, Texas
Donghui Li
UT MD Anderson Cancer Center
Houston, Texas
Daniel C. Liebler
The University of Arizona
Tucson, Arizona
Lawrence A. Loeb
University of Washington
Seattle, Washington
Michael C. MacLeod
UT M. D. Anderson Cancer Center
Smithville, Texas
Beverly Mock
NCI
Bethesda, Maryland
Hasan Mukhtar
University of Wisconsin
Madison, Wisconsin
Moshe Oren
Weizmann Institute of Science
Rehovot, Israel
Jesus Paramio
CIEMAT Instituto
Madrid, Spain
Jill Pelling
Feinberg School of Medicine
Northwestern University
Chicago, Illinois
Frederica Perera
School of Public Health
Columbia University
New York, New York
Emanuel F. Petricoin III
Center for Biologics Evaulation & Research/FDA
Bethesda, Maryland
Gerd P. Pfeifer
City of Hope National Medical Center and Beckman Research Institute
Duarte, California
Henry C. Pitot
McArdle Laboratory for Cancer Research
University of Wisconsin
Madison, Wisconsin
Takuji Tanaka
Kanazawa Medical University
Ishikawa, Japan
Nancy Raab-Traub
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina
Chinthalapally V. Rao
University of Oklahoma
Norman, Oklahoma
John C. Reed
La Jolla Cancer Research Foundation
La Jolla, California
Ze'ev Ronai
Derald H. Ruttenberg Cancer Center
Mount Sinai School of Medicine
Baltimore, Maryland
Dennis Roop
Baylor College of Medicine
Houston, Texas
Daniel Rosenberg
Center for Molecular Medicine
University of Connecticut
Farmington, Connecticut
Peter Shields
Georgetown University School of Medicine
Washington, DC
Shivendra V. Singh
Department of Pharmacology and University of Pittsburg Cancer Institute
University of Pittsburg
Pittsburg, Pennsylvania
Vladimir S. Spiegleman
Department of Dermatology, School of Medicine and Public Health
University of Wisconsin
Madison, Wisconsin
Gary Stoner
School of Medicine
Ohio State University
Columbus, Ohio
Sara Strom
UT M. D. Anderson Cancer Center
Houston, Texas
Saraswati Sukumar
The Johns Hopkins University School of Medicine
Baltimore, Maryland
Young-Joon Surh
Seoul National University
Seoul, Korea
Takashi Takahashi
Division of Molecular Oncology, Aichi Cancer Center Research Institute
Nagoya University
Nagoya, Japan
Masaaki Terada
National Cancer Center Research Institute
Tokyo, Japan
Karen Vasquez
UT M. D. Anderson Cancer Center
Smithville, Texas
Cheryl Walker
UT M. D. Anderson Cancer Center
Smithville, Texas
Michael Wargovich
South Carolina Cancer Center
Columbia, South Carolina
Wendy Weinberg
Center for Biologics Evaluation and Research
Bethesda, Maryland
Richard D. Wood
University of Pittsburgh, Hillman Cancer Center
Pittsburgh, Pennsylvania
Cao Ya
Cancer Research Institute
Xiangya School of Medicine
Hunan Province, China
Chung S. Yang
Department of Chemical Biology, Ernest Mario School of Pharmacy
Rutgers University
New Brunswick, New Jersey
Xiao-Jing Wang
Department of Pathology, Head and Neck Cancer Research
University of Colorado at Denver
Denver, Colorado
S t a f f E d i t o r
Vickie J. Williams
UT M. D. Anderson Cancer Center
Houston, Texas
E d i t o r i a l A s s i s t a n t
Chris Yeager
UT M. D. Anderson Cancer Center
Houston, Texas
A s s i s t a n t M a n a g i n g E d i t o r
Stefanie Alaimo
John Wiley & Sons
Hoboken, New Jersey
J o u r n a l P r o d u c t i o n
John Wiley & Sons
MCprod@wiley.com
Molecular Carcinogenesis
| 
